Aileron Therapeutics (NASDAQ:ALRN) inks an agreement with Lincoln Park Capital Fund, under which latter will purchase up to $15M of its common stock over a period of 36 months.

Lincoln Park made an initial purchase of $500K at $1.36/share.

Net proceeds will be used for general corporate purposes and extending cash runway to support ALRN-6924 clinical development strategy.


Source link

Comments to: Aileron Therapeutics inks $15M stock purchase deal with Lincoln Park Capital (NASDAQ:ALRN)

Your email address will not be published. Required fields are marked *

Attach images - Only PNG, JPG, JPEG and GIF are supported.


Welcome to Typer

Brief and amiable onboarding is the first thing a new user sees in the theme.
Join Typer
Registration is closed.